For instance, in a recent study, investigators sought to quell inflammation in the brain by manipulation of TGFβ and SMAD3 in immune cells as a new method to prevent Alzheimer's disease. Here, TGFB1 is linked to early-onset autosomal dominant Alzheimer disease.